Peking University Shenzhen Hospital

Urology

The Department of Urology at Peking University Shenzhen Hospital is the Shenzhen Clinical Research Center for Urinary System Diseases and the chair unit of the Pearl River Delta Hypertension Surgery Alliance. It has a urology institute, the Guangdong Provincial Key Laboratory of Reproduction and Genetics, and the Shenzhen Clinical Data and Biospecimen Bank for Major Diseases. It previously received recognition as a national key discipline of the Ministry of Education through a joint application and as a Guangdong Provincial Clinical Key Specialty. The department is the first Peking University doctoral degree-awarding site at Peking University Shenzhen Hospital, the Shenzhen branch of the Peking University Urology Physician Training Program, and the China Andrology Physician Training Base (Shenzhen). It is a national standardized residency training base, a Peking University standardized specialist training base and a Shenzhen standardized andrology training base, and in recent years has undertaken graduate teaching for Peking University, Anhui Medical University, Zunyi Medical University, Shantou University, Shenzhen University and other institutions. The department uses integrated management of outpatient services, wards and the institute. It has 66 staff members, including 27 doctors, 33 nurses and six full-time research experts; among them are 13 doctors with doctoral degrees, two postdoctoral fellows in residence, three doctoral supervisors, three master’s supervisors, two provincial high-level talents, two Shenzhen high-level talents and 18 senior clinical experts. There are 50 GCP-qualified researchers, including 25 research physicians, 25 research nurses and four PIs. The department currently has 76 open beds; annual outpatient volume peaks at nearly 100,000 visits, and annual surgical volume reaches 6,900 procedures (outpatient plus inpatient), including more than 460 robotic minimally invasive operations per year. It is equipped with internationally leading examination and treatment devices, including a da Vinci robotic system, 3D laparoscopic system, microscope system, EMS lithotripsy system, holmium laser system, 1470 laser system, intraoperative imaging and ultrasound navigation system, ureteroscope system, resectoscope system and nephroscope system. It also has cystoscopy, extracorporeal shock-wave lithotripsy, urodynamics, ultrasonography, male sexual dysfunction examination and biofeedback treatment rooms, ensuring diagnostic accuracy and treatment safety. Its robotic minimally invasive surgery, oncology, stone disease and andrology are at an advanced level in South China, and it is one of the consultation centers for difficult and critical urological diseases in South China. In recent years, the department has worked closely with leading urology teams nationwide, introducing the Three Projects team of Professor Jiang Hui from Peking University Third Hospital; inviting Professor Huang Jian of Sun Yat-sen Memorial Hospital of Sun Yat-sen University, chair of the Chinese Medical Association’s Urology Branch, as a visiting professor and establishing Professor Huang Jian’s studio; and appointing Professor Jin Jie of Peking University First Hospital as an academic consultant and establishing Professor Zhang Qian’s studio. These efforts have promoted high-quality disciplinary development. The department also routinely conducts clinical research trials involving devices and drugs. In recent years it has undertaken more than 30 research projects at various levels, including one subproject of a national major scientific research program and 12 National Natural Science Foundation projects; more than 100 SCI-indexed papers have been published, with the highest impact factor for a single paper reaching 39.3. In 2018 it ranked 44th nationally in the China Hospital Science and Technology Value ranking and has remained among the national top 100 for five consecutive years.